The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter

Annals of Nuclear Medicine

Volumn 11, Issue 4, 1997, Pages 285-290

  Karayalçin, Ümit ^a   Çiftçi, Feridun ^a   Boz, Adil ^a   Boz, Seher ^a   Karayalçin, Binnur ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Nodular goiter; Technetium 99m tetrofosmin thyroid scintigraphy; Thyroid cancer

Indexed keywords

PERTECHNETIC ACID TC 99M; TETROFOSMIN TC 99M;

ADULT; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NODULAR GOITER; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY;

EID: 2642675222     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03165295     Document Type: Article

References (20)

1. Rojeski MT, Gharib H. Nodular thyroid disease evaluation and management. N Engl J Med 313: 428-434, 1985.
2. Ernest L, Mazzaferri MD. Management of a solitary thyroid nodule. N Engl J Med 328: 553-559, 1993.
3. Brander A, Viikinkoski P, Tuuhea J. Clinical versus ultrasonographic examination of the thyroid gland in common clinical practice. J Clin Ultrasound 20: 37-42, 1992.
4. Songadale JA, Younes A, Maublant J, Veyre A, Platts EA, Pickett RD. Uptake of Tc-99m tetrofosmin in isolated mitochondria: evidence for an active mechanism (Abstract). J Nucl Med 35: 46P-47P, 1994.
5. Hamming JF, Goslings BM, van Steenis GJ. The value of fine needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of neoplasms on clinical grounds. Arch Intern Med 150: 113-116, 1990.
6. Kut Ö, Biberoǧlu S, Saydam S, et al. Utility of early and delayed T1-201 scintigraphy in the evaluation of thyroid nodules. Eur J Nucl Med 22: 908, 1995.
7. Jarzab B, Puch Z, Roskosz J, et al. Tc-99m-MIBI in the assessment of locally advanced thyroid cancer. Eur J Nucl Med 22: 769, 1995.
8. Ernest L, Mazzaferi MD. Management of a solitary thyroid nodule. N Engl J Med 328: 553-559, 1993.
9. Diwakar J, Frans J, Wackers TH. Biokinetics of Technetium-99m-tetrofosmin: Myocardial perfusion imaging agent: Implications for a one-day imaging protocol. J Nucl Med 34: 1254-1259, 1993.
10. Smith FW, Smith T, Gemmell H. Phase I study of Tc-99m diphosphine (P53) for myocardial imaging. J Nucl Med 32: 967, 1991.
11. Higley B, Smith FW, Smith T. Technetium-99m-1,2-bis (bis(2-ethoxyethyl) phosphino) Ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion agent. J Nucl Med 34: 30-38, 1993.
12. Adalet I, Demirkol O, Müslümanoǧlu M. Tc-99m tetrofosmin scintigraphy in the evaluation of palpable breast masses - preliminary results. Eur J Nucl Med 22: 742, 1995.
13. Schillaci O, Scopinaro F, Danieli R. Technetium-99m-tetrofosmin scan in breast lesions - preliminary results. Eur J Nucl Med 22: 878, 1995
14. Başoǧlu T, Şahin M, Coşkun C. Technetium-99m-tetrofosmin uptake in malignant lung tumors. Eur J Nucl Med 22: 687-689, 1995.
15. Erdil TY, Önsel Ç, Sözüdoǧru N. The value of Tc-99m tetrofosmin scintigraphy in the visualization of neoplastic lung lesions. Eur J Nucl Med 22: 774, 1995.
16. Gözükara I, Özpaçaci T, Şahin R. Utility of tetrofosmin as a tumor detector on lung Ca. Eur J Nucl Med 22: 843, 1995.
17. Lopez A, Tabuenca MJ, Novao N. Single photon emission tomography in broncogenic carcinoma using 99m-Tc-tetrofosmin. Eur J Nucl Med 22: 843, 1995
18. Gallowitsch HJ, Kresnik E, Mikosch P. Tc-99m SESTAMIBI and Tc-99m tetrofosmin scintigraphy: alternative scintigraphic methods in follow-up of DTC? First results. Eur J Nucl Med 22: 909, 1995.
19. Klain M, Maurea S, Lastoria S, Cuocolo A, Colao A, Salvatore M. Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer. J Nucl Med 36: 2248-2251, 1995.
20. Howard JD, Donald AM, Michael K. Advances in the management of patients with thyroid disease. Sem Nucl Med 26: 205-220, 1995.